Company: HYEX
Filing Date: 2025-04-22
Form Type: 10-K/A
Source: 0001096906-25-000553
Chunk: 85

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-04-22
Form: 10-K/A
Chunk 85
---
 intrinsic value of these stock warrants was $0 as the exercise price of these stock warrants were greater than the market price.

F-26

Share Conversion Agreements

All of the holders of the Company’s Series A Convertible Preferred Stock (the “Preferred Holders”) entered into a Preferred Stock Conversion Agreement. Pursuant to the Conversion Agreements, the Preferred Holders converted their shares of preferred stock into common stock, effective as of the Exchange. As a result, no shares of the Company’s Series A Convertible Preferred Stock are outstanding. An aggregate of shares of common stock were issued to the Preferred Holders. The Preferred Holders agreed to convert each share of Series A Convertible Preferred Stock into eighteen (18) shares of common stock and agreed to retire a total of shares of Series A Convertible Preferred Stock. The Company cancelled the retired shares.

Omnibus Stock Grant and Option Plan

The following summary of options activity for the year ended December 31, 2024 is presented below:

|                                                  |         |           |    Weighted- |           |
|                                                  |         | Weighted- |      Average |           |
|                                                  |         |   Average |    Remaining | Aggregate |
|                                                  |         |  Exercise |  Contractual | Intrinsic |
|                                                  | Options |     Price | Life (Years) |     Value |
| Outstanding at December 31, 2023                 |  38,333 |     $6.00 |         2.34 |    46,000 |
| Granted                                          |       - |         - |            - |         - |
| Forfeited                                        |       - |         - |            - |         - |
| Exercised                                        |       - |         - |            - |         - |
| Outstanding at December 31, 2024                 |  38,333 |     $6.00 |         1.34 |        $- |
| Vested and expected to vest at December 31, 2024 |  38,333 |     $6.00 |              |        $- |
| Exercisable at December 31, 2024                 |  38,333 |     $6.00 |              |        $- |

At December 31, 2024, the intrinsic value of these stock options was $0 as the exercise price of these stock options were greater than the market price.

The following summary of restricted stock units’ activity for the year ended December 31